Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125412412 | 12541241 | 2 | F | 201606 | 20160715 | 20160708 | 20160722 | EXP | JP-009507513-1607JPN000846 | MERCK | 70.00 | YR | M | Y | 0.00000 | 20160722 | PH | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125412412 | 12541241 | 1 | PS | REBETOL | RIBAVIRIN | 1 | Oral | 800 MG, DIVIDED DOSE FREQUENCY UNKNOWN | 20903 | CAPSULE | |||||||||
| 125412412 | 12541241 | 2 | SS | SOVALDI | SOFOSBUVIR | 1 | Oral | 400 MG,DIVIDED DOSE FREQUENCY UNKNOWN | 0 | TABLET | |||||||||
| 125412412 | 12541241 | 3 | C | TRANSFER FACTOR | 2 | Unknown | DAILY DOSE UNKNOWN | U | 0 |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125412412 | 12541241 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125412412 | 12541241 | Hyperbilirubinaemia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125412412 | 12541241 | 1 | 201606 | 0 | ||
| 125412412 | 12541241 | 2 | 201606 | 0 |